StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Mustang Bio's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $27.44M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$27.44M–
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$13.43M–
FY2018Dec 31, 2018$0–
FY2015Dec 31, 2015$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$27.58M+2.2%
Q4 FY2022Dec 31, 2022$27.44M–
Q3 FY2022Sep 30, 2022$27.29M–
Q2 FY2022Jun 30, 2022$27.15M–
Q1 FY2022Mar 31, 2022$26.99M+93.3%
Q4 FY2021Dec 31, 2021$0-100.0%
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$13.96M+376.9%
Q1 FY2020Mar 31, 2020$13.69M–
Q4 FY2019Dec 31, 2019$13.43M–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2016Sep 30, 2016$2.93M–

More Mustang Bio figures

See a number that looks wrong?